The Department of Health and Human Services (HHS), Office of Inspector General (OIG) recently issued Advisory Opinion 26-12, a favorable opinion regarding an orthopedic surgery provider’s proposed warranty that would refund certain concierge fees to patients who require revision surgery within two years of the initial procedure.

This Advisory Opinion is particularly notable because it represents one of the first instances in which OIG has applied the warranty safe harbor to a provider—rather than a manufacturer or supplier—and extended the warranty concept from products to clinical outcomes for surgical services.

The Proposed Warranty Arrangement

The requestor, an orthopedic surgery provider, offers a voluntary concierge program where patients pay fees to access certain items and services for one year following the date of a surgical procedure. Under the proposed warranty, the provider would refund concierge program fees to patients who required revision surgery within two years of the initial procedure. The concierge program was geared towards supporting patient recovery (e.g., coaching and education sessions from a wellness coach, peri-operative nutritional supplement program, membership to a wellness application that includes health data monitoring, compression garments), and patients could elect to participate in it following any surgical procedure. None of the items and services are covered by insurance, including Federal health care programs, and the fees charged to patients are consistent with their fair market value.

OIG's Application of the Warranty Safe Harbor

As a threshold matter, OIG's application of the warranty safe harbor in this context is itself notable. This safe harbor has historically been associated with manufacturers and suppliers providing warranties on products—not with providers offering guarantees tied to clinical outcomes for surgical services. OIG has issued only a handful of advisory opinions directly addressing the warranty safe harbor over the past two decades, and Advisory Opinion 26-12 appears to be one of the first instances in which OIG analyzed the safe harbor in a provider-to-patient context rather than the more typical manufacturer-to-hospital or supplier-to-provider context.

OIG determined that only certain elements of the safe harbor applied to the proposed warranty. Specifically, the safe harbor condition prohibiting a manufacturer or supplier from paying remuneration to an individual (other than a beneficiary) or entity for medical, surgical, or hospital expenses incurred by a beneficiary did not apply because: (1) the requestor would pay remuneration only to patients who are themselves Federal health care program beneficiaries, not to third parties; and (2) the remuneration is only for the cost of the items and services subject to the concierge program. This narrowing meant that OIG needed to assess only a reduced set of safe harbor conditions—all of which the requestor satisfied.

With respect to the remaining elements of the safe harbor warranty, OIG noted that the requestor certified that:

• it would fully and accurately report any refund issued under the warranty on an invoice or statement submitted to patients;
• the concierge program’s membership agreement would inform patients of their obligation to provide such information upon request by the Secretary of HHS or a state agency; and
• the warranty was not conditioned on patients' exclusive use of, or a minimum purchase of, any of the requestor's items or services.

Though the program implicates the federal Anti-Kickback Statute (AKS)—because the offer of a refund could induce patients to choose the requestor for their surgery, which may be reimbursable in whole or in part by Federal health care programs—OIG concluded that the program qualifies for the safe harbor for warranties at 42 C.F.R. § 1001.952(g). For the same reasons, OIG also concluded that it would not generate prohibited remuneration under the Beneficiary Inducements Civil Monetary Penalty (CMP) provision.

Why OIG Found Minimal Risk of Fraud and Abuse

Beyond the safe harbor analysis, several structural features of the proposed arrangement supported OIG's conclusion that it presents a low risk of fraud and abuse:

• Warranty is tied to poor outcomes—not volume or referrals: Payment flows only when the initial surgery fails and the patient requires revision surgery. Unlike rebates or discounts tied to volume, this structure does not incentivize overutilization and the provider bears direct financial risk for unsuccessful procedures.
• Remuneration flows exclusively to patients, not referral sources: Refunding patients directly rather than hospitals or other providers reduces the risk of steering patients through hidden financial relationships.
• Refunded amounts are limited to ancillary fees: Because the warranty does not affect core reimbursable surgical payments, and the items and services rendered under the concierge program are not covered by Federal health care programs, there is minimal risk of increased Federal program costs or manipulation of reimbursement streams.
• Refunds are triggered after care is delivered: The warranty is not conditioned on future utilization, and there is nothing to suggest that the arrangement incentivizes physicians to choose particular devices, steer patients toward unnecessary procedures, or otherwise distort clinical decision-making. The warranty applies regardless of the type of surgery performed, further limiting the risk of product-specific or procedure-specific steering.
• Warranty is transparent and patient-facing: The direct provider-to-patient structure is governed by a written membership agreement with clear outcome-based terms. This reduces the risk of disguised inducements that might otherwise raise AKS concerns.

Key Takeaways

Advisory Opinion 26-12 is notable in several respects. The opinion demonstrates that the warranty safe harbor can reach non-traditional settings where a provider offers a money-back guarantee tied to patient outcomes, provided the arrangement meets the applicable reporting, disclosure, and non-exclusivity conditions. It also signals OIG's increasing tolerance for outcome-based financial arrangements that align provider incentives with quality of care—a trajectory consistent with the broader shift toward value-based care in the health care industry.

OIG took care, however, to distinguish the concierge program items and services—which were paid for by patients—from the provision of free items or services in connection with surgery. OIG stated that free items and services would not be protected by the warranty safe harbor and reiterated its “longstanding and continuing concerns” regarding the provision of free items or services by physicians or entities that could lead to the ordering of items or services payable by Federal health care programs. The opinion suggests that arrangements in which a provider bears financial risk for poor outcomes—with remuneration flowing directly to patients rather than referral sources—may occupy favorable ground in OIG's evolving fraud and abuse framework. However, companies and providers contemplating warranty or satisfaction-guarantee programs in healthcare should carefully evaluate whether their arrangements meet the specific conditions of the warranty safe harbor and should be mindful of OIG's continued skepticism toward arrangements that provide free items or services that could drive utilization of federally reimbursable healthcare. 

Reed Smith will continue to monitor developments in federal fraud and abuse enforcement and OIG’s advisory opinions. If you have any questions about this advisory opinion or its implications, please contact the healthcare lawyers at Reed Smith.